| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 24.96% | Morgan Stanley | $3.65 → $2.1 | Maintains | Equal-Weight |
| 11/08/2023 | 19.01% | Telsey Advisory Group | $4 → $2 | Maintains | Market Perform |
| 10/31/2023 | 138.01% | Telsey Advisory Group | → $4 | Reiterates | Market Perform → Market Perform |
| 10/13/2023 | 138.01% | Telsey Advisory Group | → $4 | Reiterates | Market Perform → Market Perform |
| 10/04/2023 | 19.01% | Barclays | → $2 | Upgrades | Underweight → Equal-Weight |
| 08/25/2023 | 19.01% | Piper Sandler | $3 → $2 | Downgrades | Neutral → Underweight |
| 08/11/2023 | 78.51% | Canaccord Genuity | $5 → $3 | Downgrades | Buy → Hold |
| 08/10/2023 | 19.01% | Barclays | $3 → $2 | Maintains | Underweight |
| 08/09/2023 | 78.51% | Goldman Sachs | $6 → $3 | Maintains | Neutral |
| 08/09/2023 | 117.18% | Morgan Stanley | $4 → $3.65 | Maintains | Equal-Weight |
| 08/09/2023 | 138.01% | Telsey Advisory Group | $6 → $4 | Downgrades | Outperform → Market Perform |
| 08/01/2023 | 257.02% | Telsey Advisory Group | → $6 | Reiterates | Outperform → Outperform |
| 05/11/2023 | 138.01% | Morgan Stanley | $5.5 → $4 | Maintains | Equal-Weight |
| 05/10/2023 | 93.38% | B of A Securities | $4 → $3.25 | Maintains | Underperform |
| 05/10/2023 | 257.02% | Telsey Advisory Group | $7 → $6 | Maintains | Outperform |
| 05/03/2023 | 316.52% | Telsey Advisory Group | → $7 | Reiterates | → Outperform |
| 03/16/2023 | 167.76% | TD Cowen | $10 → $4.5 | Downgrades | Outperform → Market Perform |
| 03/07/2023 | 227.26% | Morgan Stanley | $6 → $5.5 | Maintains | Equal-Weight |
| 03/01/2023 | 316.52% | Telsey Advisory Group | $9 → $7 | Maintains | Outperform |
| 03/01/2023 | 257.02% | Goldman Sachs | → $6 | Downgrades | Buy → Neutral |
| 02/22/2023 | 435.52% | Telsey Advisory Group | $11 → $9 | Maintains | Outperform |
| 01/13/2023 | 376.02% | JP Morgan | $7 → $8 | Maintains | Underweight |
| 11/17/2022 | 376.02% | Canaccord Genuity | → $8 | Initiates Coverage On | → Buy |
| 11/10/2022 | 257.02% | Morgan Stanley | $6.5 → $6 | Maintains | Equal-Weight |
| 10/19/2022 | 197.51% | B of A Securities | $15 → $5 | Downgrades | Buy → Underperform |
| 10/19/2022 | 257.02% | Jefferies | $18 → $6 | Downgrades | Buy → Hold |
| 10/19/2022 | 495.03% | Truist Securities | $25 → $10 | Maintains | Buy |
| 10/19/2022 | 495.03% | Cowen & Co. | $22 → $10 | Maintains | Outperform |
| 10/19/2022 | 286.77% | Morgan Stanley | $13 → $6.5 | Downgrades | Overweight → Equal-Weight |
| 10/19/2022 | 376.02% | Piper Sandler | $12 → $8 | Maintains | Neutral |
| 10/19/2022 | 554.53% | Telsey Advisory Group | $25 → $11 | Maintains | Outperform |
| 10/19/2022 | 792.54% | Raymond James | $20 → $15 | Maintains | Strong Buy |
| 10/19/2022 | 376.02% | JP Morgan | $16 → $8 | Downgrades | Overweight → Underweight |
| 10/13/2022 | 852.04% | JP Morgan | $19 → $16 | Maintains | Overweight |
| 10/10/2022 | 911.54% | Goldman Sachs | $22 → $17 | Maintains | Buy |
| 10/04/2022 | 852.04% | Morgan Stanley | $17.5 → $16 | Maintains | Overweight |
| 09/29/2022 | 614.03% | Piper Sandler | $19 → $12 | Downgrades | Overweight → Neutral |
| 09/07/2022 | 1030.55% | Piper Sandler | $21 → $19 | Maintains | Overweight |
| 08/12/2022 | 941.29% | Morgan Stanley | $19 → $17.5 | Maintains | Overweight |
| 08/11/2022 | 792.54% | Barclays | $16 → $15 | Maintains | Equal-Weight |
| 08/10/2022 | 1209.06% | Goldman Sachs | $26 → $22 | Maintains | Buy |
| 08/10/2022 | 1090.05% | Raymond James | $24 → $20 | Maintains | Strong Buy |
| 08/10/2022 | 1149.55% | Piper Sandler | $24 → $21 | Maintains | Overweight |
| 08/03/2022 | 852.04% | Barclays | $17 → $16 | Downgrades | Overweight → Equal-Weight |
| 07/21/2022 | 1149.55% | JP Morgan | $23 → $21 | Maintains | Overweight |
| 06/16/2022 | 1328.06% | Piper Sandler | $26 → $24 | Maintains | Overweight |
| 05/12/2022 | 1209.06% | Cowen & Co. | $33 → $22 | Maintains | Outperform |
| 05/12/2022 | 1030.55% | Morgan Stanley | $31 → $19 | Maintains | Overweight |
| 05/12/2022 | 1387.56% | Telsey Advisory Group | $34 → $25 | Maintains | Outperform |
| 04/19/2022 | 1685.08% | Piper Sandler | $36 → $30 | Maintains | Overweight |
| 04/18/2022 | 1328.06% | Raymond James | $28 → $24 | Maintains | Strong Buy |
| 03/10/2022 | 1744.58% | Morgan Stanley | $34 → $31 | Maintains | Overweight |
| 03/09/2022 | 1566.07% | Raymond James | $37 → $28 | Maintains | Strong Buy |
| 03/09/2022 | 911.54% | Barclays | $29 → $17 | Upgrades | Equal-Weight → Overweight |
| 02/23/2022 | — | Jefferies | Upgrades | Hold → Buy | |
| 11/08/2021 | 1744.58% | Morgan Stanley | → $31 | Upgrades | Equal-Weight → Overweight |
| 10/25/2021 | 1804.08% | JP Morgan | → $32 | Initiates Coverage On | → Overweight |
| 10/25/2021 | 1744.58% | Morgan Stanley | → $31 | Initiates Coverage On | → Equal-Weight |
| 10/25/2021 | 2875.13% | Evercore ISI Group | → $50 | Initiates Coverage On | → Outperform |
| 10/25/2021 | 1863.58% | Cowen & Co. | → $33 | Initiates Coverage On | → Outperform |
| 10/25/2021 | 1923.09% | Goldman Sachs | → $34 | Initiates Coverage On | → Buy |
| 10/25/2021 | 1685.08% | Jefferies | → $30 | Initiates Coverage On | → Hold |
| 10/25/2021 | 1982.59% | Truist Securities | → $35 | Initiates Coverage On | → Buy |
| 10/25/2021 | 1923.09% | Piper Sandler | → $34 | Initiates Coverage On | → Overweight |
| 10/25/2021 | 2101.59% | Raymond James | → $37 | Initiates Coverage On | → Strong Buy |
| 10/25/2021 | 1923.09% | Telsey Advisory Group | → $34 | Initiates Coverage On | → Outperform |
What is the target price for Olaplex Hldgs (OLPX)?
The latest price target for Olaplex Hldgs (NASDAQ: OLPX) was reported by Morgan Stanley on November 9, 2023. The analyst firm set a price target for $2.10 expecting OLPX to rise to within 12 months (a possible 24.96% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Olaplex Hldgs (OLPX)?
The latest analyst rating for Olaplex Hldgs (NASDAQ: OLPX) was provided by Morgan Stanley, and Olaplex Hldgs maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Olaplex Hldgs (OLPX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Olaplex Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Olaplex Hldgs was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Olaplex Hldgs (OLPX) correct?
While ratings are subjective and will change, the latest Olaplex Hldgs (OLPX) rating was a maintained with a price target of $3.65 to $2.10. The current price Olaplex Hldgs (OLPX) is trading at is $1.68, which is out of the analyst's predicted range.